2017
DOI: 10.1039/c7tb02247f
|View full text |Cite|
|
Sign up to set email alerts
|

Blood brain barrier permeable gold nanocluster for targeted brain imaging and therapy: an in vitro and in vivo study

Abstract: l-Dopa conjugated fluorescent gold cluster to cross undisturbed blood brain barrier for early stage imaging and drug delivery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
39
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 50 publications
(40 citation statements)
references
References 46 publications
1
39
0
Order By: Relevance
“…The emission yield of these materials can be enhanced for potential applications in imaging, sensing, diagnosis, and therapy, but remains to be explored to its full extent . However, other nanostructures have been widely used for these applications, either due to their unique properties or due to their chemically controlled architectonics . GNRs can efficiently convert absorbed light into heat either through electron–electron interactions or electron–phonon interactions and have been established for their photothermal therapy (PTT) efficacy .…”
Section: Introductionmentioning
confidence: 99%
“…The emission yield of these materials can be enhanced for potential applications in imaging, sensing, diagnosis, and therapy, but remains to be explored to its full extent . However, other nanostructures have been widely used for these applications, either due to their unique properties or due to their chemically controlled architectonics . GNRs can efficiently convert absorbed light into heat either through electron–electron interactions or electron–phonon interactions and have been established for their photothermal therapy (PTT) efficacy .…”
Section: Introductionmentioning
confidence: 99%
“…Currently, there is no effective clinical treatment for this disease . Due to the limitation of the blood–brain barrier (BBB), medicine cannot be effectively sent to the expected diseased region . As previously reported, the efficiency of drug delivery to the brain has been shown to be reduced to less than 5% .…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, CPDs have potential clinical application in early stage diagnosis and treatment of brain disorders, when the blood–brain barrier is not disrupted or loosened. 8 , 59 In addition, CPDs also have the promise to noninvasively target many malignant brain tumors with uncompromised BBB, such as glioblastoma multiforme and anaplastic astrocytoma. 9 …”
Section: Resultsmentioning
confidence: 99%